[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Quick Uptakes
December 26, 2001

Not-so-Informed Consent

Author Affiliations

Not Available

Not Available

JAMA. 2001;286(24):3071. doi:10.1001/jama.286.24.3071-JQU10011-5-1

Therapeutic misconceptions are common among patients even after they sign informed consent statements asserting that they fully comprehend the pros and cons of clinical trials, said Boston researchers in a study appearing in the November 24 issue of The Lancet.

In the study, which was conducted at Dana-Farber Cancer Institute, Massachusetts General Hospital, and Brigham and Women's Hospital, 205 adult cancer patients who had recently enrolled in phase 1, 2, and 3 clinical trials in Boston completed questionnaires about their understanding of the studies.